Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market

Emmaus Life Sciences (EMMA) Financial Statements

85 Followers

Emmaus Life Sciences Financial Overview

Emmaus Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.077; its P/E ratio is -0.92; Emmaus Life Sciences is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 7.07M$ 5.02M$ 10.76M$ 6.75M$ 5.93M
Gross Profit$ 6.88M$ 4.80M$ 10.25M$ 6.32M$ 5.29M
EBIT$ 6.07M$ -1.64M$ 277.00K$ -1.98M$ 4.13M
EBITDA$ 6.80M$ -1.05M$ 970.00K$ -1.39M$ 4.66M
Net Income Common Stockholders$ -2.46M$ 67.00K$ -1.48M$ -3.50M$ 3.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.55M$ 1.50M$ 1.36M$ 1.77M$ 2.02M
Total Assets$ 35.18M$ 47.45M$ 50.30M$ 48.83M$ 48.23M
Total Debt$ 19.09M$ 2.90M$ 32.67M$ 33.00M$ 30.44M
Net Debt$ 16.54M$ 1.40M$ 31.30M$ 31.23M$ 28.42M
Total Liabilities$ 69.37M$ 83.78M$ 85.32M$ 84.90M$ 82.32M
Stockholders Equity$ -47.76M$ -36.33M$ -35.03M$ -35.95M$ -34.09M
Cash Flow-
Free Cash Flow$ 1.03M$ 58.00K$ -1.32M$ -1.29M$ 1.67M
Operating Cash Flow$ 1.04M$ 58.00K$ -1.32M$ -1.28M$ 1.68M
Investing Cash Flow$ -6.00K$ -399.00K$ 1.06M$ -1.09M$ -1.06M
Financing Cash Flow$ -5.00K$ 494.00K$ -153.00K$ 2.14M$ 170.00K
Currency in USD

Emmaus Life Sciences Earnings and Revenue History

Emmaus Life Sciences Debt to Assets

Emmaus Life Sciences Cash Flow

Emmaus Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis